Daniel Thompson
About Daniel Thompson
Daniel Thompson serves as the Executive Director of Sales at Mirati Therapeutics, where he has worked since 2021. He has extensive experience in sales leadership roles across various companies, including Kite Pharma and Medivation.
Work at Mirati Therapeutics
Daniel Thompson serves as the Executive Director of Sales at Mirati Therapeutics, a position he has held since 2021. In this role, he has collaborated with internal partners to develop and execute a commercial sales strategy that has exceeded sales goals. He has also led the design and build-out of the KRAS commercial oncology sales team. Additionally, he developed and implemented a next-generation field sales representative model aimed at enhancing service offerings and improving the performance of the commercial team.
Previous Experience at Kite Pharma
Prior to his current role, Daniel Thompson worked at Kite Pharma in various capacities. He served as the Executive Director of Cellular Therapy from 2019 to 2021. Before that, he was the Regional Account Director from 2017 to 2019. His tenure at Kite Pharma spanned a total of four years, during which he contributed to the company's sales and account management strategies.
Career at Metagenics and Medivation
Daniel Thompson held the position of Director of Sales & Sales Operations at Metagenics from 2010 to 2012. His responsibilities included overseeing sales operations on the West Coast. Following this role, he worked at Medivation as an Area Business Manager from 2012 to 2017. His five-year tenure at Medivation involved managing business operations and sales strategies in the West Coast region.
Education and Expertise
Daniel Thompson studied Business Administration with a focus on Marketing at Oregon State University, where he earned his Bachelor of Science degree from 1996 to 1999. He also attended Mountain View High School from 1992 to 1995. His educational background has equipped him with the skills necessary for his roles in sales and management within the biotechnology and pharmaceutical industries.